文献速递妇科产科

因良性指征行子宫切除术或子宫肌瘤剔除术女性中隐匿性妇科癌症

Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.
PubMed 文献 · Obstet Gynecol · 2018-01-01

基于2014-2015年美国外科医师学会国家手术质量改进计划的二次分析,纳入24076例子宫切除术和2368例子宫肌瘤剔除术女性。子宫切除术者隐匿性子宫体、宫颈、卵巢恶性肿瘤患病率分别为1.44%、0.60%、0.19%,且随年龄和手术路径变化;肌瘤剔除术者子宫体恶性肿瘤为0.21%。

要点

  • 子宫切除术者隐匿性子宫体恶性肿瘤患病率为1.44%(95%CI 1.29-1.59%)。
  • 腹腔镜次全子宫切除术中子宫体恶性肿瘤率为0.23%,低于全腹腔镜或腹腔镜辅助阴式子宫切除术的1.89%。
  • 年龄≥55岁较40-54岁者术前未检测到子宫体恶性肿瘤的调整比值比为6.46(95%CI 4.96-8.41)。

核心结论

  • 子宫切除术女性中隐匿性子宫体、宫颈、卵巢恶性肿瘤患病率分别为1.44%、0.60%、0.19%,且随患者年龄和手术路径变化。

研究设计与样本

  • 对2014-2015年美国外科医师学会国家手术质量改进计划数据的二次分析,纳入24076例子宫切除术和2368例子宫肌瘤剔除术女性。

主要发现

  • 子宫切除术者子宫体恶性肿瘤患病率为1.44%(95%CI 1.29-1.59%)。
  • 子宫体恶性肿瘤患病率在腹腔镜次全子宫切除术中为0.23%(95%CI 0.06-0.58%),在全腹腔镜或腹腔镜辅助阴式子宫切除术中为1.89%(95%CI 1.65-2.14%)。
  • 年龄≥55岁较40-54岁者术前未检测到子宫体恶性肿瘤的调整比值比为6.46(95%CI 4.96-8.41)。
  • 子宫切除术者宫颈恶性肿瘤患病率为0.60%(95%CI 0.50-0.70%),卵巢恶性肿瘤患病率为0.19%(95%CI 0.14-0.25%)。
  • 子宫肌瘤剔除术者子宫体恶性肿瘤患病率为0.21%(95%CI 0.03-0.40%),未发现隐匿性宫颈或卵巢恶性肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the prevalence of corpus uteri, cervix uteri, and ovarian malignancy in women undergoing hysterectomy or myomectomy for presumed benign indications. METHODS: We conducted a secondary analysis of data from the 2014-2015 American College of Surgeons National Surgical Quality Improvement Program. Adult women undergoing hysterectomies and myomectomies without evidence for known or suspected cancer at the beginning of surgery were identified from the database. Our primary outcome measure was pathology-confirmed malignancy in the corpus uteri, cervix uteri, and ovary. We performed adjusted logistic regression analysis to examine the association of patient characteristics with the risk for malignancy. RESULTS: Our sample included 24,076 women undergoing hysterectomy and 2,368 women undergoing myomectomy. Malignancy of the corpus uteri was found in 1.44% (95% CI 1.29-1.59%) of the women undergoing hysterectomy. The prevalence varied considerably across surgical routes with the rate being 0.23% (95% CI 0.06-0.58%) in laparoscopic supracervical hysterectomy and 1.89% (95% CI 1.65-2.14%) in total laparoscopic or laparoscopic-assisted vaginal hysterectomy. Older women were significantly more likely to have preoperatively undetected malignancy of the corpus uteri (adjusted odds ratio 6.46, 95% CI 4.96-8.41 for age 55 years or older vs age 40-54 years). Additionally, 0.60% (95% CI 0.50-0.70%) and 0.19% (95% CI 0.14-0.25%) of the women undergoing hysterectomy were found to have malignancy of the cervix uteri and the ovary, respectively. Among patients undergoing myomectomy, 0.21% (95% CI 0.03-0.40%) were found to have malignancy of the corpus uteri with no occult cervical or ovarian cancer identified. CONCLUSION: Prevalence of occult corpus uteri, cervical, and ovarian malignancy was 1.44%, 0.60%, and 0.19%, respectively, among women undergoing hysterectomy and it varied by patient age and surgical route.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Desai VB, Wright JD, Schwartz PE, et al. Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications. Obstet Gynecol. 2018. PMID: 29528920. doi:10.1097/AOG.0000000000002521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。